Our results display that in response to estradiol, PAX2 is phosphorylated and activated in breasts cancer cells from the luminal subtype selectively, via ER; further, modulation of PAX2 appearance in these cells straight impacts their intrusive ability, within an ER-dependent manner

Our results display that in response to estradiol, PAX2 is phosphorylated and activated in breasts cancer cells from the luminal subtype selectively, via ER; further,…